labiotech3h
Five biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates
Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...
STAT3d
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...
Most People Actually Aren’t That Into Ozempic, Survey Finds
A new survey shows that most people would rather try dieting to lose weight than take the latest injectable drugs like ...
Onlymyhealth6d
4 Best Supplements For Diabetes That Lower Blood Sugar Naturally
GlucoRedi is a supplement product that helps control blood sugar levels. It has a compelling blend of organic antioxidants ...
Here's Why Everybody's Talking About Scholar Rock Right Now
If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...
3 No-Brainer Growth Stocks to Buy in October
Three Fool.com contributors have identified what they believe are no-brainer growth stocks to buy in October. Here's why they picked Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex ...
Tory leadership hopeful Robert Jenrick urges overweight Brits to copy him and use Ozempic to shed the pounds if their doctor recommends the drug
The former immigration minister, who lost four stone in 12 months, said the drug had aided him at the start of his bid to ...
EurekAlert!4d
NIH launches large study to tackle type 2 diabetes in young people
The National Institutes of Health has launched a nationwide consortium to address the dramatic rise in youth diagnosed with type 2 diabetes over the past two decades, a trend that is expected to ...
Novo Nordisk A/S (NVO) Bullish on Wegovy Launch in International Markets
In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other best stocks to buy ...
Eli Lilly and Company (LLY): Stock That Will Make You Rich in 5-10 Years
We recently compiled a list of the 10 stocks that will make you rich in 5-10 years. In this article, we are going to take a ...
pharmaphorum3d
Noom offers cut-price compounded GLP-1 drug for obesity
Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide ... and claiming that the prices of GLP-1 drugs for weight loss are five ...